Description

MOXIFINITY Dry Syrup contains Amoxycillin 200 mg and Potassium Clavulanate 28.5 mg, formulated to provide broad-spectrum antibacterial coverage, especially in pediatric patients. Amoxycillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Potassium Clavulanate acts as a beta-lactamase inhibitor, protecting Amoxycillin from enzymatic degradation and extending its antibacterial spectrum.

This dry syrup is commonly prescribed for respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections in children. The formulation is reconstituted with water, ensuring accurate dosing, better palatability, and improved compliance.

Key Highlights:

• Contains Amoxycillin 200 mg + Potassium Clavulanate 28.5 mg

• Broad-spectrum antibacterial action

• Effective against beta-lactamase–producing bacteria

• Suitable for pediatric bacterial infections

• Easy-to-prepare dry syrup formulation

• Ensures accurate dosing and better compliance

• To be used under medical supervision

Dosage and duration should be followed strictly as prescribed by the physician to ensure safe and effective treatment.

If you want Monopoly PCD Franchise In Panchkula then please contact us.